Novartis AG Operating Income 2010-2024 | NVS

Novartis AG operating income for the twelve months ending September 30, 2024 was $13.596B, a 65.26% increase year-over-year.

  • Novartis AG annual operating income for 2023 was $9.769B, a 22.94% increase from 2022.
  • Novartis AG annual operating income for 2022 was $7.946B, a 32.02% decline from 2021.
  • Novartis AG annual operating income for 2021 was $11.689B, a 15.14% increase from 2020.

Novartis AG Operating Income 2010-2024 | NVS

  • Novartis AG annual operating income for 2023 was $9.769B, a 22.94% increase from 2022.
  • Novartis AG annual operating income for 2022 was $7.946B, a 32.02% decline from 2021.
  • Novartis AG annual operating income for 2021 was $11.689B, a 15.14% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$710.1B
Novo Nordisk (NVO)$471.5B
Johnson & Johnson (JNJ)$373.6B
AbbVie (ABBV)$312.7B
Merck (MRK)$250.9B
AstraZeneca (AZN)$203.5B
Pfizer (PFE)$145.4B
Sanofi (SNY)$122.5B
Innoviva (INVA)$1.2B